feed,title,long_url,short_url
SeekingAlpha,Biohaven phase 3 trial in genetic muscle disorder fails to reach significance overall due to low disease progression,https://seekingalpha.com/news/3841662,
SeekingAlpha,CubeSmart stock edges up after Raymond James upgrades to Strong Buy,https://seekingalpha.com/news/3841663,
